Polyrizon

Polyrizon R&D per Employee

The R&D Spending per Employee of Polyrizon (PLRZ) as of Nov 20, 2026 is 2.13 M USD. In the previous year, R&D Spending per Employee was 534,000.00 USD — a change of 299.44% (higher).

R&D per Employee

2.13 MUSD

YoY

299.44%

Last updated:

R&D Spending per Employee of Polyrizon is 2025 2.13 M USD. R&D Spending per Employee of Polyrizon was 2024 534,000.00 USD. It decreases by 299.44% higher compared to the previous year.

The Polyrizon R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2020
38,000.00 USD
Jan 1, 2021
245,000.00 USD
Jan 1, 2022
347,000.00 USD
Jan 1, 2023
332,000.00 USD
Jan 1, 2024
534,000.00 USD
Jan 1, 2025
2.13 M USD
The Polyrizon R&D per Employee history
YEARR&D per EmployeeYoY
2.13 MUSD+299.44%
534,000.00USD+60.84%
332,000.00USD-4.32%
347,000.00USD+41.63%
245,000.00USD+544.74%
38,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

R&D Spending per Employee of Polyrizon is 2.13 M USD in 2025.

R&D Spending per Employee of Polyrizon changed from 534,000.00 USD to 2.13 M USD, representing a 299.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Polyrizon since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Polyrizon historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Polyrizon

All Key Metrics — Polyrizon